MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Alta Partners
Finance & Acquisitions: Alta Partners
Parents
Alta Partners
Children
*Portfolio Companies: Alta
2007: By March 2007, it had raised $50 million from New Leaf Venture Partners, Quilvest Ventures, New Enterprise Associates, Venrock Associates, Alta Partners, Omega Fund, and Granite Global Ventures.
2011: Participants include New Enterprise Associates, Aberdare Ventures, Alta Partners and Thomas, McNerney & Partners.(2011)
Aerie’s venture capital backers include TPG Ventures, Alta Partners and Sofinnova Ventures.
Alta Partners
aTyr Pharma has just raised $23 million in Series C financing from Domain Associates, Alta Partners, Cardinal Partners and Polar
Calistoga Pharmaceuticals is a private, venture backed company with top tier investors including Alta Partners, Amgen Ventures, Frazier Healthcare, Latterell Venture Partners, Quogue Capital and Three Arch Partners. (2011)
David Mack, Ph.D., Director at Alta Partners, joined Pathwork Diagnostics' board of directors in connection with the financing.
Existing backers SV Life Sciences and Alta Partners also participated.
Existing investors Alta Partners and Domain Associates participated in the round, as well as a new investor AKS Capital
Had raised at least $36 million from a Series B round that included investors such as Alta Partners, Clarus Ventures, High Country Venture, and Sanderling Ventures (2011)
Hamilton BioVentures and Alta Partners led the deal, which included MPM Capital and Investor Growth Capital
In December, 2006 SARcode secured $25 million in a financing co-led by Clarus Ventures and Alta Partners.
Investors: Advanced Technology Ventures (ATV), Alta Partners, Astellas Venture Capital, CW Ventures, Daiwa, SMBC Capital, GIMV, Kumho Asiana Group, Pappas Ventures ,Walden International
Investors: Frazier Healthcare Ventures, Alta Partners, 5 AM Ventures, ARCH Venture Partners, Domain Associates, Venrock Associates, Versant Ventures and the Wellcome Trust
Investors: Quogue Capital, Alta Partners, Amgen Ventures, Frazier Healthcare, Three Arch Partners and Latterell Venture Partners
Kite Pharma (NASDAQ:KITE)*
Led by Alta Partners, the financing included participation from the company's existing investors: Abingworth, Advent Venture Par
Participants include Alta Partners, Cardinal Partners and Polaris Ventures.
Participants include ProQuest Investments, Column Group, Versant Ventures and Alta Partners.
Participants include Rho Ventures, Alta Partners, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Mitsubishi International and MVM Life Science Partners.
San Francisco-based Telegraph Hill Partners and Alta Partners
Scynexis’ investors include Alta Partners, Burrill & Company, KBL Healthcare Ventures, Societe Generale, Ventech, CDC Innovation and SR One, the venture capital arm of GlaxoSmithKline (NYSE:GSK).
Series C Investor(s) Endeavour Vision, Silicon Valley Bank, Adams Street Partners, Telegraph Hill Partners, Spray Venture Partners, Forbion Capital Partners, Alta Partners, Leader Ventures
The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
The series F round was led by New Leaf Venture Partners, joined by new investors Pappas Ventures and Morningside Group. Existing investors Canaan Partners, Sanderling Ventures, Alta Partners, Asset Management Company and Frazier Healthcare Ventures also pa
ZS Pharma (NASDAQ:ZSPH)
Jumps
*Key People: Alta
Organization & Developments: Alta Partners